|
US4460577A
(en)
*
|
1977-09-30 |
1984-07-17 |
Farmitalia Carlo Erba S.P.A. |
Pharmaceutical compositions consisting or consisting essentially of liposomes, and processes for making same
|
|
US4356167A
(en)
*
|
1978-01-27 |
1982-10-26 |
Sandoz, Inc. |
Liposome drug delivery systems
|
|
DE2925009A1
(de)
*
|
1979-06-21 |
1981-01-08 |
Basf Ag |
Zubereitung fuer substanzen, verfahren zu deren herstellung und deren verwendung
|
|
CA1173360A
(en)
*
|
1979-06-22 |
1984-08-28 |
Jurg Schrank |
Pharmaceutical preparations
|
|
EP0032622B1
(en)
*
|
1979-12-20 |
1985-08-14 |
Dennis Chapman |
Polymerisable phospholipids and polymers thereof, methods for their preparation, methods for their use in coating substrates and forming liposomes and the resulting coated substrates and liposome compositions
|
|
US4933114A
(en)
*
|
1980-08-11 |
1990-06-12 |
Eastman Kodak Company |
Polyacetylenic lipids, radiation-sensitive compositions, photographic elements and processes relating to same
|
|
JPS5782310A
(en)
*
|
1980-11-11 |
1982-05-22 |
Tanabe Seiyaku Co Ltd |
Production of liposome preparation
|
|
NL193099C
(nl)
*
|
1981-10-30 |
1998-11-03 |
Novo Industri As |
Gestabiliseerde insuline-oplossing.
|
|
FR2521565B1
(fr)
*
|
1982-02-17 |
1985-07-05 |
Dior Sa Parfums Christian |
Melange pulverulent de constituants lipidiques et de constituants hydrophobes, procede pour le preparer, phases lamellaires lipidiques hydratees et procede de fabrication, compositions pharmaceutiques ou cosmetiques comportant des phases lamellaires lipidiques hydratees
|
|
US4425334A
(en)
|
1982-04-02 |
1984-01-10 |
The Regents Of The University Of California |
Functional oxygen transport system
|
|
US4612370A
(en)
*
|
1982-04-02 |
1986-09-16 |
The Regents Of The University Of California |
Lipid-saccharide reaction products
|
|
GB2135647A
(en)
*
|
1983-02-15 |
1984-09-05 |
Squibb & Sons Inc |
Method of preparing liposomes and products produced thereby
|
|
US5186941A
(en)
*
|
1983-05-06 |
1993-02-16 |
Vestar, Inc. |
Vesicle formulation for the controlled release of therapeutic agents
|
|
US4515736A
(en)
*
|
1983-05-12 |
1985-05-07 |
The Regents Of The University Of California |
Method for encapsulating materials into liposomes
|
|
JPS607932A
(ja)
*
|
1983-06-29 |
1985-01-16 |
Dai Ichi Seiyaku Co Ltd |
リポソーム懸濁液およびその製法
|
|
US4744989A
(en)
*
|
1984-02-08 |
1988-05-17 |
E. R. Squibb & Sons, Inc. |
Method of preparing liposomes and products produced thereby
|
|
US5141674A
(en)
*
|
1984-03-08 |
1992-08-25 |
Phares Pharmaceutical Research N.V. |
Methods of preparing pro-liposome dispersions and aerosols
|
|
JPS60239417A
(ja)
*
|
1984-05-15 |
1985-11-28 |
Sankyo Co Ltd |
エマルシヨン凍結乾燥製剤の製法
|
|
SE8403905D0
(sv)
*
|
1984-07-30 |
1984-07-30 |
Draco Ab |
Liposomes and steroid esters
|
|
US4880635B1
(en)
*
|
1984-08-08 |
1996-07-02 |
Liposome Company |
Dehydrated liposomes
|
|
US5736155A
(en)
*
|
1984-08-08 |
1998-04-07 |
The Liposome Company, Inc. |
Encapsulation of antineoplastic agents in liposomes
|
|
CA1270198A
(en)
*
|
1984-08-08 |
1990-06-12 |
Marcel B. Bally |
Encapsulation of antineoplastic agents in liposomes
|
|
AU587600B2
(en)
*
|
1985-01-11 |
1989-08-24 |
Regents Of The University Of California, The |
Method for preserving liposomes
|
|
US4857319A
(en)
*
|
1985-01-11 |
1989-08-15 |
The Regents Of The University Of California |
Method for preserving liposomes
|
|
US4830858A
(en)
*
|
1985-02-11 |
1989-05-16 |
E. R. Squibb & Sons, Inc. |
Spray-drying method for preparing liposomes and products produced thereby
|
|
IE58981B1
(en)
*
|
1985-10-15 |
1993-12-15 |
Vestar Inc |
Anthracycline antineoplastic agents encapsulated in phospholipid micellular particles
|
|
US4806343A
(en)
*
|
1986-03-13 |
1989-02-21 |
University Of Southwestern Louisiana |
Cryogenic protectant for proteins
|
|
SE8601457D0
(sv)
*
|
1986-04-01 |
1986-04-01 |
Draco Ab |
Compositions of liposomes and b?712-receptor active substances for inhalation
|
|
US4839175A
(en)
*
|
1986-07-28 |
1989-06-13 |
Liposome Technology, Inc. |
Liposomes with enhanced retention on mucosal tissue
|
|
WO1988000824A1
(en)
*
|
1986-07-28 |
1988-02-11 |
Liposome Technology, Inc. |
Liposomes with enhanced retention on mucosal tissue
|
|
US4804539A
(en)
*
|
1986-07-28 |
1989-02-14 |
Liposome Technology, Inc. |
Ophthalmic liposomes
|
|
US4818537A
(en)
*
|
1986-10-21 |
1989-04-04 |
Liposome Technology, Inc. |
Liposome composition for treating dry eye
|
|
FR2634375B3
(fr)
*
|
1988-06-30 |
1991-07-05 |
Centre Nat Rech Scient |
Procede de preparation de systemes colloidaux dispersibles de lipide amphiphiles sous forme de liposomes submicroniques
|
|
US5089181A
(en)
*
|
1987-02-24 |
1992-02-18 |
Vestar, Inc. |
Method of dehydrating vesicle preparations for long term storage
|
|
AU612631B2
(en)
*
|
1987-02-24 |
1991-07-18 |
Vestar, Inc. |
Dehydrating vesicule preparations for long-term storage
|
|
US5616334A
(en)
*
|
1987-03-05 |
1997-04-01 |
The Liposome Company, Inc. |
Low toxicity drug-lipid systems
|
|
US6406713B1
(en)
|
1987-03-05 |
2002-06-18 |
The Liposome Company, Inc. |
Methods of preparing low-toxicity drug-lipid complexes
|
|
US4863739A
(en)
*
|
1987-05-19 |
1989-09-05 |
Board Of Regents, The University Of Texas System |
Liposome compositions of anthracycline derivatives
|
|
US5925375A
(en)
*
|
1987-05-22 |
1999-07-20 |
The Liposome Company, Inc. |
Therapeutic use of multilamellar liposomal prostaglandin formulations
|
|
AU617678B2
(en)
*
|
1987-05-22 |
1991-12-05 |
Liposome Company, Inc., The |
Prostaglandin-lipid formulations
|
|
US5262168A
(en)
*
|
1987-05-22 |
1993-11-16 |
The Liposome Company, Inc. |
Prostaglandin-lipid formulations
|
|
US4963362A
(en)
*
|
1987-08-07 |
1990-10-16 |
Regents Of The University Of Minnesota |
Freeze-dried liposome mixture containing cyclosporin
|
|
US5178875A
(en)
*
|
1991-01-14 |
1993-01-12 |
The Board Of Regents, The University Of Texas System |
Liposomal-polyene preliposomal powder and method for its preparation
|
|
US4950432A
(en)
*
|
1987-10-16 |
1990-08-21 |
Board Of Regents, The University Of Texas System |
Polyene microlide pre-liposomal powders
|
|
US5830498A
(en)
*
|
1987-10-16 |
1998-11-03 |
Board Of Regents, The University Of Texas System |
Liposomal-polyene preliposomal powder and method for its preparation
|
|
MX9203804A
(es)
*
|
1987-10-19 |
1992-07-01 |
Liposome Co Inc |
Sistemas farmaceuticos a base de tocoferol.
|
|
AU608415B2
(en)
*
|
1988-01-19 |
1991-03-28 |
University Of Texas System, The |
Esters of 3'-deaminodoxorubicin, liposomal compositions thereof
|
|
JPH01160962U
(US07714131-20100511-C00038.png)
*
|
1988-04-28 |
1989-11-08 |
|
|
|
US5096629A
(en)
*
|
1988-08-29 |
1992-03-17 |
501 Nippon Fine Chemical Co., Ltd. |
Method for preparing lipid powder for use in preparing liposomes and method for preparing liposomes
|
|
ATE107502T1
(de)
*
|
1988-10-05 |
1994-07-15 |
Vestar Inc |
Verfahren zur herstellung von liposomen mit verbesserter stabilität während des trocknens.
|
|
US4931361A
(en)
*
|
1988-11-18 |
1990-06-05 |
California Institute Of Technology |
Cryoprotective reagents in freeze-drying membranes
|
|
JP2807741B2
(ja)
*
|
1988-12-22 |
1998-10-08 |
コレチカ |
リポソームの安定化方法、安定化リポソーム組成物、ならびにそれを含む医薬組成物および化粧料組成物
|
|
US20020150539A1
(en)
|
1989-12-22 |
2002-10-17 |
Unger Evan C. |
Ultrasound imaging and treatment
|
|
US5656211A
(en)
*
|
1989-12-22 |
1997-08-12 |
Imarx Pharmaceutical Corp. |
Apparatus and method for making gas-filled vesicles of optimal size
|
|
US5580575A
(en)
*
|
1989-12-22 |
1996-12-03 |
Imarx Pharmaceutical Corp. |
Therapeutic drug delivery systems
|
|
US6146657A
(en)
*
|
1989-12-22 |
2000-11-14 |
Imarx Pharmaceutical Corp. |
Gas-filled lipid spheres for use in diagnostic and therapeutic applications
|
|
US5773024A
(en)
*
|
1989-12-22 |
1998-06-30 |
Imarx Pharmaceutical Corp. |
Container with multi-phase composition for use in diagnostic and therapeutic applications
|
|
US6001335A
(en)
*
|
1989-12-22 |
1999-12-14 |
Imarx Pharmaceutical Corp. |
Contrasting agents for ultrasonic imaging and methods for preparing the same
|
|
US6088613A
(en)
|
1989-12-22 |
2000-07-11 |
Imarx Pharmaceutical Corp. |
Method of magnetic resonance focused surgical and therapeutic ultrasound
|
|
US5542935A
(en)
*
|
1989-12-22 |
1996-08-06 |
Imarx Pharmaceutical Corp. |
Therapeutic delivery systems related applications
|
|
US5922304A
(en)
*
|
1989-12-22 |
1999-07-13 |
Imarx Pharmaceutical Corp. |
Gaseous precursor filled microspheres as magnetic resonance imaging contrast agents
|
|
US5733572A
(en)
*
|
1989-12-22 |
1998-03-31 |
Imarx Pharmaceutical Corp. |
Gas and gaseous precursor filled microspheres as topical and subcutaneous delivery vehicles
|
|
US5776429A
(en)
*
|
1989-12-22 |
1998-07-07 |
Imarx Pharmaceutical Corp. |
Method of preparing gas-filled microspheres using a lyophilized lipids
|
|
US6551576B1
(en)
|
1989-12-22 |
2003-04-22 |
Bristol-Myers Squibb Medical Imaging, Inc. |
Container with multi-phase composition for use in diagnostic and therapeutic applications
|
|
US5352435A
(en)
*
|
1989-12-22 |
1994-10-04 |
Unger Evan C |
Ionophore containing liposomes for ultrasound imaging
|
|
US5305757A
(en)
*
|
1989-12-22 |
1994-04-26 |
Unger Evan C |
Gas filled liposomes and their use as ultrasonic contrast agents
|
|
US5469854A
(en)
*
|
1989-12-22 |
1995-11-28 |
Imarx Pharmaceutical Corp. |
Methods of preparing gas-filled liposomes
|
|
US5585112A
(en)
|
1989-12-22 |
1996-12-17 |
Imarx Pharmaceutical Corp. |
Method of preparing gas and gaseous precursor-filled microspheres
|
|
US5882678A
(en)
*
|
1990-01-12 |
1999-03-16 |
The Liposome Co, Inc. |
Interdigitation-fusion liposomes containing arachidonic acid metabolites
|
|
IN172208B
(US07714131-20100511-C00038.png)
*
|
1990-04-02 |
1993-05-01 |
Sint Sa |
|
|
US20010024638A1
(en)
*
|
1992-11-02 |
2001-09-27 |
Michel Schneider |
Stable microbubble suspensions as enhancement agents for ultrasound echography and dry formulations thereof
|
|
US6613306B1
(en)
|
1990-04-02 |
2003-09-02 |
Bracco International B.V. |
Ultrasound contrast agents and methods of making and using them
|
|
US20040208826A1
(en)
*
|
1990-04-02 |
2004-10-21 |
Bracco International B.V. |
Ultrasound contrast agents and methods of making and using them
|
|
US6989141B2
(en)
*
|
1990-05-18 |
2006-01-24 |
Bracco International B.V. |
Ultrasound contrast agents and methods of making and using them
|
|
US5445813A
(en)
*
|
1992-11-02 |
1995-08-29 |
Bracco International B.V. |
Stable microbubble suspensions as enhancement agents for ultrasound echography
|
|
US5578292A
(en)
|
1991-11-20 |
1996-11-26 |
Bracco International B.V. |
Long-lasting aqueous dispersions or suspensions of pressure-resistant gas-filled microvesicles and methods for the preparation thereof
|
|
US7083778B2
(en)
*
|
1991-05-03 |
2006-08-01 |
Bracco International B.V. |
Ultrasound contrast agents and methods of making and using them
|
|
USRE39146E1
(en)
|
1990-04-02 |
2006-06-27 |
Bracco International B.V. |
Long-lasting aqueous dispersions or suspensions of pressure-resistant gas-filled microvesicles and methods for the preparation thereof
|
|
US20030194376A1
(en)
*
|
1990-05-18 |
2003-10-16 |
Bracco International B.V. |
Ultrasound contrast agents and methods of making and using them
|
|
AU636481B2
(en)
*
|
1990-05-18 |
1993-04-29 |
Bracco International B.V. |
Polymeric gas or air filled microballoons usable as suspensions in liquid carriers for ultrasonic echography
|
|
DK0555229T3
(da)
*
|
1990-07-31 |
1996-08-19 |
Liposome Co Inc |
Akkumulation af aminosyrer og peptider i liposomer
|
|
US5556637A
(en)
*
|
1990-08-06 |
1996-09-17 |
A. Nattermann & Cie. Gmbh |
Water containing liposome system
|
|
US5205290A
(en)
*
|
1991-04-05 |
1993-04-27 |
Unger Evan C |
Low density microspheres and their use as contrast agents for computed tomography
|
|
US5874062A
(en)
*
|
1991-04-05 |
1999-02-23 |
Imarx Pharmaceutical Corp. |
Methods of computed tomography using perfluorocarbon gaseous filled microspheres as contrast agents
|
|
IL104084A
(en)
*
|
1992-01-24 |
1996-09-12 |
Bracco Int Bv |
Sustainable aqueous suspensions of pressure-resistant and gas-filled blisters, their preparation, and contrast agents containing them
|
|
JP2711619B2
(ja)
*
|
1992-07-23 |
1998-02-10 |
理化学研究所 |
殺菌殺虫組成物
|
|
US5578709A
(en)
*
|
1993-03-09 |
1996-11-26 |
Middlesex Sciences, Inc. |
Macromolecular microparticles and methods of production
|
|
US5554730A
(en)
*
|
1993-03-09 |
1996-09-10 |
Middlesex Sciences, Inc. |
Method and kit for making a polysaccharide-protein conjugate
|
|
US6090925A
(en)
|
1993-03-09 |
2000-07-18 |
Epic Therapeutics, Inc. |
Macromolecular microparticles and methods of production and use
|
|
ATE210966T1
(de)
*
|
1993-05-21 |
2002-01-15 |
Liposome Co Inc |
Reduzierung von durch liposome induzierte physiologischen gegenreaktionen
|
|
WO1995003035A1
(en)
*
|
1993-07-23 |
1995-02-02 |
Massachusetts Institute Of Technology |
Polymerized liposomes with enhanced stability for oral delivery
|
|
US6004534A
(en)
*
|
1993-07-23 |
1999-12-21 |
Massachusetts Institute Of Technology |
Targeted polymerized liposomes for improved drug delivery
|
|
DK0725629T3
(da)
*
|
1993-10-25 |
2000-08-07 |
Liposome Co Inc |
Liposomale defensiner
|
|
DE69409361T2
(de)
*
|
1993-11-05 |
1998-11-12 |
Amgen Inc |
Herstellung von liposomen und verfahren zur substanzverkapselung
|
|
US7083572B2
(en)
|
1993-11-30 |
2006-08-01 |
Bristol-Myers Squibb Medical Imaging, Inc. |
Therapeutic delivery systems
|
|
NZ276167A
(en)
*
|
1993-12-15 |
1996-11-26 |
Bracco Research Sa |
Ultrasound contrast medium comprising two gases in aqueous suspension
|
|
US5736121A
(en)
*
|
1994-05-23 |
1998-04-07 |
Imarx Pharmaceutical Corp. |
Stabilized homogenous suspensions as computed tomography contrast agents
|
|
US6066331A
(en)
*
|
1994-07-08 |
2000-05-23 |
Barenholz; Yechezkel |
Method for preparation of vesicles loaded with biological structures, biopolymers and/or oligomers
|
|
US6156337A
(en)
*
|
1994-07-08 |
2000-12-05 |
Opperbas Holding B.V. |
Method for high loading of vesicles with biopolymeric substances
|
|
AU703933B2
(en)
*
|
1994-07-12 |
1999-04-01 |
Berwind Pharmaceutical Services, Inc. |
Moisture barrier film coating composition, method, and coated form
|
|
DE4430592A1
(de)
*
|
1994-08-20 |
1996-02-22 |
Max Delbrueck Centrum |
Liposomale Zubereitung, ihre Herstellung und ihre Verwendung
|
|
US5589189A
(en)
*
|
1994-09-14 |
1996-12-31 |
Nexstar Pharmaceuticals, Inc. |
Liposome dispersion
|
|
IL115099A
(en)
*
|
1994-10-14 |
1999-04-11 |
Upjohn Co |
Lyophilizate of phospholipid complex of water insoluble camptothecins
|
|
US6743779B1
(en)
|
1994-11-29 |
2004-06-01 |
Imarx Pharmaceutical Corp. |
Methods for delivering compounds into a cell
|
|
US5830430A
(en)
*
|
1995-02-21 |
1998-11-03 |
Imarx Pharmaceutical Corp. |
Cationic lipids and the use thereof
|
|
US5997898A
(en)
*
|
1995-06-06 |
1999-12-07 |
Imarx Pharmaceutical Corp. |
Stabilized compositions of fluorinated amphiphiles for methods of therapeutic delivery
|
|
US6139819A
(en)
*
|
1995-06-07 |
2000-10-31 |
Imarx Pharmaceutical Corp. |
Targeted contrast agents for diagnostic and therapeutic use
|
|
US6231834B1
(en)
|
1995-06-07 |
2001-05-15 |
Imarx Pharmaceutical Corp. |
Methods for ultrasound imaging involving the use of a contrast agent and multiple images and processing of same
|
|
US6033645A
(en)
*
|
1996-06-19 |
2000-03-07 |
Unger; Evan C. |
Methods for diagnostic imaging by regulating the administration rate of a contrast agent
|
|
US6521211B1
(en)
|
1995-06-07 |
2003-02-18 |
Bristol-Myers Squibb Medical Imaging, Inc. |
Methods of imaging and treatment with targeted compositions
|
|
US5855911A
(en)
*
|
1995-08-29 |
1999-01-05 |
Board Of Regents, The University Of Texas System |
Liposomal phosphodiester, phosphorothioate, and P-ethoxy oligonucleotides
|
|
DE19605175A1
(de)
|
1996-02-13 |
1997-08-14 |
Sourovoi Andrej Dr |
Lipidverbindungen und deren Verwendung
|
|
US6117449A
(en)
*
|
1996-03-22 |
2000-09-12 |
Bio-Sphere Technology, Inc. |
Method for inducing a systemic immune response to a hepatitis antigen
|
|
US6207185B1
(en)
|
1996-03-22 |
2001-03-27 |
Bio-Sphere Technology |
Method for inducing a systemic immune response to an HIV antigen
|
|
US6015576A
(en)
*
|
1997-08-29 |
2000-01-18 |
Bio-Sphere Technology, Inc. |
Method for inducing a systemic immune response to an antigen
|
|
CA2174803C
(en)
*
|
1996-04-23 |
2000-07-11 |
Jonathan P. Wong |
Use of liposome encapsulated ciprofloxacin as an immunotherapeutic drug
|
|
AU736301B2
(en)
|
1996-05-01 |
2001-07-26 |
Imarx Therapeutics, Inc. |
Methods for delivering compounds into a cell
|
|
US6093816A
(en)
*
|
1996-06-27 |
2000-07-25 |
Isis Pharmaceuticals, Inc. |
Cationic lipids
|
|
US7309692B1
(en)
*
|
1996-07-08 |
2007-12-18 |
Board Of Regents, The University Of Texas System |
Inhibition of chronic myelogenous leukemic cell growth by liposomal-antisense oligodeoxy-nucleotides targeting to GRB2 or CRK1
|
|
US6414139B1
(en)
|
1996-09-03 |
2002-07-02 |
Imarx Therapeutics, Inc. |
Silicon amphiphilic compounds and the use thereof
|
|
US5846517A
(en)
|
1996-09-11 |
1998-12-08 |
Imarx Pharmaceutical Corp. |
Methods for diagnostic imaging using a renal contrast agent and a vasodilator
|
|
ES2189974T3
(es)
*
|
1996-09-11 |
2003-07-16 |
Imarx Pharmaceutical Corp |
Procedimientos mejorados para la obtencion de imagenes de diagnostico usando un agente de contraste y un vasodilatador.
|
|
US6977244B2
(en)
*
|
1996-10-04 |
2005-12-20 |
Board Of Regents, The University Of Texas Systems |
Inhibition of Bcl-2 protein expression by liposomal antisense oligodeoxynucleotides
|
|
US6120751A
(en)
|
1997-03-21 |
2000-09-19 |
Imarx Pharmaceutical Corp. |
Charged lipids and uses for the same
|
|
US6090800A
(en)
*
|
1997-05-06 |
2000-07-18 |
Imarx Pharmaceutical Corp. |
Lipid soluble steroid prodrugs
|
|
US6143276A
(en)
*
|
1997-03-21 |
2000-11-07 |
Imarx Pharmaceutical Corp. |
Methods for delivering bioactive agents to regions of elevated temperatures
|
|
US6537246B1
(en)
|
1997-06-18 |
2003-03-25 |
Imarx Therapeutics, Inc. |
Oxygen delivery agents and uses for the same
|
|
US6060082A
(en)
*
|
1997-04-18 |
2000-05-09 |
Massachusetts Institute Of Technology |
Polymerized liposomes targeted to M cells and useful for oral or mucosal drug delivery
|
|
US7452551B1
(en)
|
2000-10-30 |
2008-11-18 |
Imarx Therapeutics, Inc. |
Targeted compositions for diagnostic and therapeutic use
|
|
US6416740B1
(en)
|
1997-05-13 |
2002-07-09 |
Bristol-Myers Squibb Medical Imaging, Inc. |
Acoustically active drug delivery systems
|
|
JP2001514209A
(ja)
*
|
1997-09-04 |
2001-09-11 |
バイオゾーン ラボラトリーズ，インコーポレイテッド |
経口リポソーム送達系
|
|
US6548047B1
(en)
|
1997-09-15 |
2003-04-15 |
Bristol-Myers Squibb Medical Imaging, Inc. |
Thermal preactivation of gaseous precursor filled compositions
|
|
US6518412B1
(en)
|
1997-09-29 |
2003-02-11 |
Jean-Louis Dasseux |
Gene therapy approaches to supply apolipoprotein A-I agonists and their use to treat dyslipidemic disorders
|
|
US6004925A
(en)
|
1997-09-29 |
1999-12-21 |
J. L. Dasseux |
Apolipoprotein A-I agonists and their use to treat dyslipidemic disorders
|
|
US6037323A
(en)
*
|
1997-09-29 |
2000-03-14 |
Jean-Louis Dasseux |
Apolipoprotein A-I agonists and their use to treat dyslipidemic disorders
|
|
US6046166A
(en)
*
|
1997-09-29 |
2000-04-04 |
Jean-Louis Dasseux |
Apolipoprotein A-I agonists and their use to treat dyslipidemic disorders
|
|
US6033708A
(en)
*
|
1997-09-30 |
2000-03-07 |
The United States Of America As Represented By The Secretary Of The Navy |
Method for producing sterile filterable liposome dispersion
|
|
US6287590B1
(en)
|
1997-10-02 |
2001-09-11 |
Esperion Therapeutics, Inc. |
Peptide/lipid complex formation by co-lyophilization
|
|
US7704962B1
(en)
|
1997-10-03 |
2010-04-27 |
Board Of Regents, The University Of Texas System |
Small oligonucleotides with anti-tumor activity
|
|
US7285288B1
(en)
|
1997-10-03 |
2007-10-23 |
Board Of Regents, The University Of Texas System |
Inhibition of Bcl-2 protein expression by liposomal antisense oligodeoxynucleotides
|
|
US6123923A
(en)
*
|
1997-12-18 |
2000-09-26 |
Imarx Pharmaceutical Corp. |
Optoacoustic contrast agents and methods for their use
|
|
US20010003580A1
(en)
|
1998-01-14 |
2001-06-14 |
Poh K. Hui |
Preparation of a lipid blend and a phospholipid suspension containing the lipid blend
|
|
GB9902527D0
(en)
*
|
1999-02-04 |
1999-03-24 |
Phares Pharm Res Nv |
Compositions
|
|
WO2001020999A1
(en)
*
|
1999-09-23 |
2001-03-29 |
Trimedyne, Inc. |
Materials and methods for inducing angiogenesis and the repair of mammalian tissue
|
|
US20040009229A1
(en)
*
|
2000-01-05 |
2004-01-15 |
Unger Evan Charles |
Stabilized nanoparticle formulations of camptotheca derivatives
|
|
US7282215B2
(en)
*
|
2000-05-08 |
2007-10-16 |
The University Of British Columbia |
Supports for photosensitizer formulations
|
|
PL363618A1
(en)
*
|
2000-11-09 |
2004-11-29 |
Neopharm, Inc. |
Sn-38 lipid complexes and methods of use
|
|
AU2002219998B2
(en)
*
|
2000-12-01 |
2006-03-02 |
Biomira, Inc. |
Preparation of large liposomes by infusion into peg
|
|
WO2003030864A1
(en)
*
|
2001-05-29 |
2003-04-17 |
Neopharm, Inc. |
Liposomal formulation of irinotecan
|
|
WO2003061386A1
(en)
*
|
2002-01-03 |
2003-07-31 |
Board Of Regents, The University Of Texas System |
Wt1 antisense oligos for the inhibition of breast cancer
|
|
US20030134423A1
(en)
*
|
2002-01-04 |
2003-07-17 |
Chu Yong Liang |
Compounds for delivering substances into cells
|
|
US20030219473A1
(en)
*
|
2002-03-26 |
2003-11-27 |
Leila Zarif |
Cochleates made with purified soy phosphatidylserine
|
|
US20030212046A1
(en)
*
|
2002-05-07 |
2003-11-13 |
Kapac, Llc |
Methods and formulations for enhancing the absorption and gastro-intestinal bioavailability of hydrophobic drugs
|
|
US20060093661A1
(en)
|
2002-05-07 |
2006-05-04 |
Kapac, Llc |
Methods and formulations for enhancing the absorption and gastro-intestinal bioavailability of hydrophobic drugs
|
|
CN1245153C
(zh)
*
|
2002-06-06 |
2006-03-15 |
上海家化联合股份有限公司 |
一种维生素a脂质体及其制备方法
|
|
US20060030578A1
(en)
*
|
2002-08-20 |
2006-02-09 |
Neopharm, Inc. |
Pharmaceutically active lipid based formulation of irinotecan
|
|
AU2003296897A1
(en)
*
|
2002-08-20 |
2004-05-04 |
Neopharm, Inc. |
Pharmaceutical formulations of camptothecine derivatives
|
|
US20040247624A1
(en)
*
|
2003-06-05 |
2004-12-09 |
Unger Evan Charles |
Methods of making pharmaceutical formulations for the delivery of drugs having low aqueous solubility
|
|
US20080045575A1
(en)
*
|
2004-12-29 |
2008-02-21 |
Van Dyke Thomas E |
Delivery of H2 Antagonists
|
|
US20080094573A1
(en)
*
|
2006-04-04 |
2008-04-24 |
Vermette Patrick |
Surface-modified materials, such as contact lenses, methods and kits for their preparation, and uses thereof
|
|
MX2008015337A
(es)
*
|
2006-06-01 |
2009-11-26 |
Inst Cardiologie Montreal |
Metodo y compuesto para el tratamiento de estenosis valvular.
|
|
ES2400162T3
(es)
*
|
2006-10-06 |
2013-04-08 |
Scil Technology Gmbh |
Formación de vesículas reconstituidas y secadas para un uso farmacéutico
|
|
US20080124387A1
(en)
|
2006-11-27 |
2008-05-29 |
Kapac, Llc |
Methods and formulations for enhancing the absorption and decreasing the absorption variability of orally administered drugs, vitamins and nutrients
|
|
WO2008135855A2
(en)
|
2007-05-03 |
2008-11-13 |
Pfizer Products Inc. |
Nanoparticles comprising a cholesteryl ester transfer protein inhibitor and a nonionizable polymer
|
|
US8309129B2
(en)
|
2007-05-03 |
2012-11-13 |
Bend Research, Inc. |
Nanoparticles comprising a drug, ethylcellulose, and a bile salt
|
|
WO2008149230A2
(en)
|
2007-06-04 |
2008-12-11 |
Pfizer Products Inc. |
Nanoparticles comprising drug, a non-ionizable cellulosic polymer and tocopheryl polyethylene glycol succinate
|
|
WO2008149192A2
(en)
|
2007-06-04 |
2008-12-11 |
Pfizer Products Inc. |
Nanoparticles comprising a non-ionizable cellulosic polymer and an amphiphilic non-ionizable block copolymer
|
|
US20090088393A1
(en)
*
|
2007-09-28 |
2009-04-02 |
Zomanex, Llc |
Methods and formulations for converting intravenous and injectable drugs into oral dosage forms
|
|
US20090092538A1
(en)
|
2007-10-08 |
2009-04-09 |
Amit Khanolkar |
Methods for forming stabilized metal salt particles
|
|
WO2009073215A1
(en)
|
2007-12-06 |
2009-06-11 |
Bend Research, Inc. |
Pharmaceutical compositions comprising nanoparticles and a resuspending material
|
|
WO2009073216A1
(en)
|
2007-12-06 |
2009-06-11 |
Bend Research, Inc. |
Nanoparticles comprising a non-ionizable polymer and an amine-functionalized methacrylate copolymer
|
|
EP2396017B1
(en)
|
2009-02-16 |
2015-07-01 |
Cerenis Therapeutics Holding SA |
Apolipoprotein a-i mimics
|
|
EP2445472B1
(de)
|
2009-06-24 |
2017-12-27 |
Lipoid GmbH |
Zusammensetzung für kosmetische, pharmazeutische oder diätetische anwendungen
|
|
EP2394640A1
(en)
|
2010-05-21 |
2011-12-14 |
MediGene AG |
Improved liposomal formulations of lipophilic compounds
|
|
EP2585046A4
(en)
*
|
2010-06-23 |
2013-11-06 |
Brightside Innovations Inc |
LECITHINTRÄGERVESIKEL AND METHOD FOR THE PRODUCTION THEREOF
|
|
JP2012102043A
(ja)
*
|
2010-11-10 |
2012-05-31 |
Konica Minolta Holdings Inc |
単胞リポソームの製造方法、単胞リポソームの分散液とその乾燥粉末及びそれらの製造方法
|
|
EP4154915A1
(en)
|
2014-12-31 |
2023-03-29 |
Lantheus Medical Imaging, Inc. |
Lipid-encapsulated gas microsphere compositions and related methods
|
|
US10188749B2
(en)
|
2016-04-14 |
2019-01-29 |
Fred Hutchinson Cancer Research Center |
Compositions and methods to program therapeutic cells using targeted nucleic acid nanocarriers
|
|
CA3020857A1
(en)
|
2016-04-14 |
2017-10-19 |
Fred Hutchinson Cancer Research Center |
Compositions and methods to program therapeutic cells using targeted nucleic acid nanocarriers
|
|
MX2018013409A
(es)
|
2016-05-04 |
2019-07-08 |
Lantheus Medical Imaging Inc |
Métodos y dispositivos para la preparación de agentes de contraste de ultrasonido.
|
|
US9789210B1
(en)
|
2016-07-06 |
2017-10-17 |
Lantheus Medical Imaging, Inc. |
Methods for making ultrasound contrast agents
|
|
US20190336532A1
(en)
|
2016-12-21 |
2019-11-07 |
Fred Hutchinson Cancer Research Center |
Scaffolds to treat solid tumor cells and escape variants
|
|
CA3049244A1
(en)
|
2017-01-05 |
2018-07-12 |
Fred Hutchinson Cancer Research Center |
Systems and methods to improve vaccine efficacy
|
|
CA3143631A1
(en)
|
2019-06-20 |
2020-12-24 |
Janssen Sciences Ireland Unlimited Company |
Lipid nanoparticle or liposome delivery of hepatitis b virus (hbv) vaccines
|
|
WO2022133230A1
(en)
|
2020-12-18 |
2022-06-23 |
Janssen Pharmaceuticals, Inc. |
Combination therapy for treating hepatitis b virus infection
|
|
WO2023233290A1
(en)
|
2022-05-31 |
2023-12-07 |
Janssen Sciences Ireland Unlimited Company |
Rnai agents targeting pd-l1
|
